{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:28:29Z","timestamp":1790717309551,"version":"4.1.0"},"reference-count":38,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"3","license":[{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"DOI":"10.1167\/tvst.9.3.29","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T18:31:07Z","timestamp":1582655467000},"page":"29","source":"Crossref","is-referenced-by-count":46,"title":["Dupilumab-Associated Mucin Deficiency (DAMD)"],"prefix":"10.1167","volume":"9","author":[{"given":"Brad P.","family":"Barnett","sequence":"first","affiliation":[{"name":"Duke University Eye Center, Duke University Medical Center, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie A.","family":"Afshari","sequence":"additional","affiliation":[{"name":"Shiley Eye Institute, University of California San Diego, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","published-online":{"date-parts":[[2020,2,25]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1111\/jdv.2019.33.issue-7","article-title":"Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy - international eczema council survey and opinion","volume":"33","author":"Thyssen","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/17512433.2018.1449642","article-title":"Dupilumab for treatment of atopic dermatitis","volume":"11","author":"Seegraber","year":"2018","journal-title":"Expert Rev Clin Pharmacol"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.18176\/jiaci","article-title":"Dupilumab: a new paradigm for the treatment of allergic diseases","volume":"28","author":"Sastre","year":"2018","journal-title":"J Investig Allergol Clin Immunol"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","article-title":"Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma","volume":"378","author":"Rabe","year":"2018","journal-title":"N Engl J Med"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1056\/NEJMc1700366","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"376","author":"Mennini","year":"2017","journal-title":"N Engl J Med"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nature10863","article-title":"Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine","volume":"483","author":"McDole","year":"2012","journal-title":"Nature"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/mi.2014.58","article-title":"Microbial sensing by goblet cells controls immune surveillance of luminal antigens in the colon","volume":"8","author":"Knoop","year":"2015","journal-title":"Mucosal Immunol"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1111\/bjd.2019.180.issue-5","article-title":"Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis","volume":"180","author":"Bakker","year":"2019","journal-title":"Br J Dermatol"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.intimp.2017.11.031","article-title":"Adverse events of Dupilumab in adults with moderate-to-severe atopic dermatitis: a meta-analysis","volume":"54","author":"Ou","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1016\/S0140-6736(17)31191-1","article-title":"Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial","volume":"389","author":"Blauvelt","year":"2017","journal-title":"Lancet"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/bjd.2018.178.issue-5","article-title":"Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFE)","volume":"178","author":"de Bruin-Weller","year":"2018","journal-title":"Br J Dermatol"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1001\/jamadermatol.2018.2690","article-title":"Risk factors for dupilumab-associated conjunctivitis in patients with atopic dermatitis","volume":"154","author":"Treister","year":"2018","journal-title":"JAMA Dermatol"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.jaip.2018.10.055","article-title":"Letter regarding \u201cConjunctivitis occurring in atopic dermatitis patients treated with dupilumab-clinical characteristics and treatment\u201d","volume":"7","author":"Rial","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ajoc.2017.06.017","article-title":"Cicatricial ectropion in a patient treated with dupilumab","volume":"7","author":"Barnes","year":"2017","journal-title":"Am J Ophthalmol Case Rep"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/bjd.2018.178.issue-4","article-title":"Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a critical appraisal","volume":"178","author":"Thomson","year":"2018","journal-title":"Br J Dermatol"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"375","author":"Simpson","year":"2016","journal-title":"N Engl J Med"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1001\/jamadermatol.2018.3427","article-title":"Cicatrizing blepharoconjunctivitis occurring during dupilumab treatment and a proposed algorithm for its management","volume":"154","author":"Levine","year":"2018","journal-title":"JAMA Dermatol"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.1167\/iovs.14-15496","article-title":"IL-13 stimulates proliferation and expression of mucin and immunomodulatory genes in cultured conjunctival goblet cells","volume":"56","author":"Tukler Henriksson","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1001\/jamaophthalmol.2014.1008","article-title":"Alteration of tear mucin 5AC in office workers using visual display terminals: The Osaka Study","volume":"132","author":"Uchino","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.molmed.2015.06.003","article-title":"Three cheers for the goblet cell: maintaining homeostasis in mucosal epithelia","volume":"21","author":"McCauley","year":"2015","journal-title":"Trends Mol Med"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1073\/pnas.1416922112","article-title":"IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells","volume":"112","author":"Guenova","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.4049\/jimmunol.1602144","article-title":"IFN-gamma-expressing Th17 cells are required for development of severe ocular surface autoimmunity","volume":"199","author":"Chen","year":"2017","journal-title":"J Immunol"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/ACI.0b013e32830e6b04","article-title":"Functions of ocular surface mucins in health and disease","volume":"8","author":"Mantelli","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/mi.2013.7","article-title":"Resolvin D1 and aspirin-triggered resolvin D1 regulate histamine-stimulated conjunctival goblet cell secretion","volume":"6","author":"Li","year":"2013","journal-title":"Mucosal Immunol"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"4951","DOI":"10.1167\/iovs.10-7068","article-title":"Mouse conjunctival forniceal gene expression during postnatal development and its regulation by Kruppel-like factor 4","volume":"52","author":"Gupta","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ajpath.2013.03.017","article-title":"Spdef null mice lack conjunctival goblet cells and provide a model of dry eye","volume":"183","author":"Marko","year":"2013","journal-title":"Am J Pathol"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1242\/dev.082842","article-title":"Mastermind-like transcriptional co-activator-mediated Notch signaling is indispensable for maintaining conjunctival epithelial identity","volume":"140","author":"Zhang","year":"2013","journal-title":"Development"},{"key":"bib28","first-page":"1004","article-title":"Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjogren syndrome","volume":"43","author":"Argueso","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2298\/MPNS0206195V","article-title":"Distribution and density of conjunctival goblet cells","volume":"55","author":"Vujkovic","year":"2002","journal-title":"Med Pregl"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"e29017","DOI":"10.1371\/journal.pone.0029017","article-title":"Disruption of TGF-beta signaling improves ocular surface epithelial disease in experimental autoimmune keratoconjunctivitis sicca","volume":"6","author":"De Paiva","year":"2011","journal-title":"PLoS One"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.4049\/jimmunol.1000833","article-title":"Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation","volume":"186","author":"Dartt","year":"2011","journal-title":"J Immunol"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.exer.2013.11.011","article-title":"Topical interferon-gamma neutralization prevents conjunctival goblet cell loss in experimental murine dry eye","volume":"118","author":"Zhang","year":"2014","journal-title":"Exp Eye Res"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"e0120284","DOI":"10.1371\/journal.pone.0120284","article-title":"Immunomodulatory cross-talk between conjunctival goblet cells and dendritic cells","volume":"10","author":"Contreras-Ruiz","year":"2015","journal-title":"PLoS One"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"636812","DOI":"10.1155\/2013\/636812","article-title":"Modulation of conjunctival goblet cell function by inflammatory cytokines","volume":"2013","author":"Contreras-Ruiz","year":"2013","journal-title":"Mediators Inflamm"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1080\/02713680802149115","article-title":"Topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis: an open-label pilot study","volume":"33","author":"Attas-Fox","year":"2008","journal-title":"Curr Eye Res"},{"key":"bib36","first-page":"488","article-title":"Management of dupilumab-associated conjunctivitis in atopic dermatitis","volume":"17","author":"Aszodi","year":"2019","journal-title":"J Dtsch Dermatol Ges"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1111\/bjd.2018.178.issue-5","article-title":"Could conjunctivitis in patients with atopic dermatitis treated with dupilumab be caused by colonization with Demodex and increased interleukin-17 levels? Reply from the authors","volume":"178","author":"de Bruin-Weller","year":"2018","journal-title":"Br J Dermatol"},{"key":"bib38","first-page":"1","article-title":"Dupilumab-induced follicular conjunctivitis","author":"Shen","year":"2018","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2762181","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T19:01:45Z","timestamp":1588359705000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2762181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,25]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,2,7]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.9.3.29","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2,25]]}}}